Famciclovir Patent Expiration
Famciclovir is Used for treating shingles infections. It was first introduced by Novartis Pharmaceuticals Corp
Famciclovir Patents
Given below is the list of patents protecting Famciclovir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Famvir |
US5840763 (Pediatric) | Treatment of a latent infection of herpes viruses |
Mar 01, 2016
(Expired) | Novartis |
| Famvir |
US5916893 (Pediatric) | Treatment of a latent infection of herpes virus |
Mar 01, 2016
(Expired) | Novartis |
| Famvir | US5840763 | Treatment of a latent infection of herpes viruses |
Sep 01, 2015
(Expired) | Novartis |
| Famvir | US5916893 | Treatment of a latent infection of herpes virus |
Sep 01, 2015
(Expired) | Novartis |
| Famvir |
US5866581 (Pediatric) | Penciclovir for the treatment of post therapeutic neuralgia |
Apr 04, 2015
(Expired) | Novartis |
| Famvir |
US6124304 (Pediatric) | Penciclovir for the treatment of zoster associated pain |
Apr 04, 2015
(Expired) | Novartis |
| Famvir | US5866581 | Penciclovir for the treatment of post therapeutic neuralgia |
Oct 04, 2014
(Expired) | Novartis |
| Famvir | US6124304 | Penciclovir for the treatment of zoster associated pain |
Oct 04, 2014
(Expired) | Novartis |
Famciclovir's Family Patents
Explore Our Curated Drug Screens
Famciclovir Generic API Manufacturers
Several generic applications have been filed for Famciclovir. The first generic version for Famciclovir was by Teva Pharmaceuticals Usa and was approved on Aug 24, 2007. And the latest generic version is by Hetero Labs Ltd Unit V and was approved on Sep 10, 2014.
Given below is the list of companies who have filed for Famciclovir generic, along with the locations of their manufacturing plants worldwide.
1. APOTEX
Apotex Inc has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 125MG | tablet | Prescription | ORAL | AB | Jul 22, 2011 |
| 250MG | tablet | Prescription | ORAL | AB | Jul 22, 2011 |
| 500MG | tablet | Prescription | ORAL | AB | Jul 22, 2011 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
2. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 125MG | tablet | Prescription | ORAL | AB | Mar 21, 2011 |
| 500MG | tablet | Prescription | ORAL | AB | Mar 21, 2011 |
| 250MG | tablet | Prescription | ORAL | AB | Mar 21, 2011 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
3. CIPLA
Cipla Ltd has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 125MG | tablet | Discontinued | ORAL | N/A | Mar 21, 2011 |
| 250MG | tablet | Discontinued | ORAL | N/A | Mar 21, 2011 |
| 500MG | tablet | Discontinued | ORAL | N/A | Mar 21, 2011 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
4. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 125MG | tablet | Prescription | ORAL | AB | Sep 10, 2014 |
| 250MG | tablet | Prescription | ORAL | AB | Sep 10, 2014 |
| 500MG | tablet | Prescription | ORAL | AB | Sep 10, 2014 |
5. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet | Discontinued | ORAL | N/A | Mar 21, 2011 |
| 125MG | tablet | Discontinued | ORAL | N/A | Mar 21, 2011 |
| 250MG | tablet | Discontinued | ORAL | N/A | Mar 21, 2011 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
6. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet | Prescription | ORAL | AB | Jan 12, 2012 |
| 250MG | tablet | Prescription | ORAL | AB | Jan 12, 2012 |
| 125MG | tablet | Prescription | ORAL | AB | Jan 12, 2012 |
7. NATCO PHARMA
Natco Pharma Ltd has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Natco Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet | Discontinued | ORAL | N/A | Mar 24, 2011 |
| 250MG | tablet | Discontinued | ORAL | N/A | Mar 24, 2011 |
| 125MG | tablet | Discontinued | ORAL | N/A | Mar 24, 2011 |
Manufacturing Plant Locations New
Natco Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Natco Pharma as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||
8. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 250MG | tablet | Prescription | ORAL | AB | Aug 24, 2007 |
| 500MG
(reference standard) | tablet | Prescription | ORAL | AB | Aug 24, 2007 |
| 125MG | tablet | Prescription | ORAL | AB | Aug 24, 2007 |